DECAMP 1 PLUS Proposal: Prediction of Lung Cancer Using Noninvasive Biomarkers
Recruiting
18 years - 99 years
All
66 participants needed
1 Location
Brief description of study
The DECAMP 1 PLUS study will expand on previous early detection studies (DECAMP 1 and 2) to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules. This study will investigate molecular, clinical and imaging features that may distinguish benign versus malignant disease among smokers with indeterminate pulmonary nodules in both a screening (Arm 1) and an incidental (Arm 2) clinical setting.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Lung Cancer, indeterminate pulmonary nodules
-
Age: 18 years - 99 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 843762